Literature DB >> 30383441

18F-FDG PET-CT in paediatric oncology: established and emerging applications.

Greg Chambers1, Russell Frood1, Chirag Patel1, Andrew Scarsbrook1,2.   

Abstract

Accurate staging and response assessment is vital in the management of childhood malignancies. Fluorine-18 fluorodeoxyglucose positron emission tomography/CT (FDG PET-CT) provides complimentary anatomical and functional information. Oncological applications of FDG PET-CT are not as well-established within the paediatric population compared to adults. This article will comprehensively review established oncological PET-CT applications in paediatric oncology and provide an overview of emerging and future developments in this domain.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30383441      PMCID： PMC6404840          DOI： 10.1259/bjr.20180584

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  8 in total

1.  Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.

Authors:  Yu-Mo Zhao; Ying-He Li; Tao Chen; Wei-Guang Zhang; Lin-Hao Wang; Jiatai Feng; Chenwei Li; Xu Zhang; Wei Fan; Ying-Ying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

2.  Handheld PET Probe for Pediatric Cancer Surgery.

Authors:  Hannah N Rinehardt; Sadie Longo; Ryan Gilbert; Jennifer N Shoaf; Wilson B Edwards; Gary Kohanbash; Marcus M Malek
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

Review 3.  Clinical application of 18F-DOPA PET/TC in pediatric patients.

Authors:  Gabriele Masselli; Emanuele Casciani; Cristina De Angelis; Saadi Sollaku; Gianfranco Gualdi
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

Review 4.  PET/CT in pediatric oncology.

Authors:  Gabriele Masselli; Cristina De Angelis; Saadi Sollaku; Emanuele Casciani; Gianfranco Gualdi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

5.  Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.

Authors:  Elizabeth M Holland; Bonnie Yates; Alex Ling; Constance M Yuan; Hao-Wei Wang; Maryalice Stetler-Stevenson; Michael LaLoggia; John C Molina; Daniel A Lichtenstein; Daniel W Lee; John A Ligon; Haneen Shalabi; Mark A Ahlman; Nirali N Shah
Journal:  Blood Adv       Date:  2022-04-12

6.  The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma.

Authors:  Janet Denise Reed; Andries Masenge; Ane Buchner; Fareed Omar; David Reynders; Mariza Vorster; Christophe Van de Wiele; Mike Sathekge
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

Review 7.  Clinical Perspectives for 18F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics.

Authors:  Vassiliki Lyra; Sofia Chatziioannou; Maria Kallergi
Journal:  Metabolites       Date:  2022-02-28

8.  Diagnostic Performance of 18F-FDG PET(CT) in Bone-Bone Marrow Involvement in Pediatric Neuroblastoma: A Systemic Review and Meta-Analysis.

Authors:  Lixin Sun; Bingye Zhang; Ruchen Peng
Journal:  Contrast Media Mol Imaging       Date:  2021-06-16       Impact factor: 3.161
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.